Bipolar Disorder
One in five pregnant women report using CBD-only products
Twenty percent of pregnant women reported using CBD-only products during pregnancy despite limited available data on potential adverse outcomes of CBD, according to findings published in Obstetrics & Gynecology.
Impact of interpreter use on psychiatric treatment, care access requires further study
NEW YORK — Additional research concerning the impact of using interpreters for psychiatric care for patients with limited English proficiency is needed, according to a poster presented at the American Psychiatric Association Annual Meeting.
Q&A: Keto diet may improve symptoms of severe mental illness
Results of a small pilot study suggest that the ketogenic diet may help counter adverse metabolic effects of psychotropic medications and improve mental health among adults with schizophrenia or bipolar disorder.
Psychiatric diagnosis not associated with worse outcomes after fracture-related infection
According to results published in Orthopedics, patients with vs. without psychiatric diagnoses, such as depression, bipolar disorder, anxiety disorder and schizophrenia, had similar clinical outcomes after fracture-related infection.
FDA approves Fanapt for bipolar disorder in adults
The FDA has approved Fanapt tablets for the acute treatment of manic or mixed episodes associated with bipolar I disorder in adults.
Link between psychedelic use, manic symptoms in teens may be associated with genetics
While psychedelic use may be associated with fewer psychotic symptoms among adolescents, the link between psychedelics and manic symptoms appears to be associated with genetic vulnerability to schizophrenia or bipolar disorder, data show.
Smartphone app identifies, predicts depressive symptoms with vocal biomarkers
A smartphone app demonstrated the ability to evaluate vocal biomarkers in a 30-second voice sample to identify and predict elevated mental health symptoms, according to a study published in Frontiers in Psychiatry.
Sleep improvement in hospital greater for those with acute mania compared with MDD
Individuals with mania who were admitted to an acute care psychiatric unit saw greater sleep improvement than patients with major depressive disorder, according to a study.
Less toxic lithium treatment for major depressive disorder set for phase 2a study
A potential next-generation lithium treatment is set to be tested in major depressive disorder after the FDA issued a “study may proceed” letter for a phase 2a trial of AL001 by Alzamend Neuro.
Researchers identify neural markers to determine risk for mania vs. depression
Neural markers can reliably distinguish mania/hypomania-specific risk from depression-specific risk in young adults, according to a study published in JAMA Psychiatry.